The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling.
Autorzy:
Worth AA; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom. Shoop R; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom. Tye K; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom. Feetham CH; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom. D'Agostino G; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.; Rowett Institute, University of Aberdeen, Aberdeen, United Kingdom. Dodd GT; School of Biomedical Sciences, The University of Melbourne, Victoria, Australia. Reimann F; Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom. Gribble FM; Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom. Beebe EC; Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, United States. Dunbar JD; Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, United States. Alexander-Chacko JT; Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, United States. SindelarDK; Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, United States. Coskun T; Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, United States. Emmerson PJ; Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, United States. Luckman SM; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Pokaż więcej
Źródło:
ELife [Elife] 2020 Jul 29; Vol. 9. Date of Electronic Publication: 2020 Jul 29.
Indole Glucocorticoid Receptor Antagonists Active in a Model of Dyslipidemia Act via a Unique Association with an Agonist Binding Site.
Autorzy:
Luz JG; Eli Lilly Biotechnology Center , 10300 Campus Point Drive, Suite 200, San Diego, California 92121 United States. Carson MW; Lilly Research Laboratories, A Division of Eli Lilly & Co. , Lilly Corporate Center, Indianapolis, Indiana 46285 United States. Condon B; Eli Lilly Biotechnology Center , 10300 Campus Point Drive, Suite 200, San Diego, California 92121 United States. Clawson D; Lilly Research Laboratories, A Division of Eli Lilly & Co. , Lilly Corporate Center, Indianapolis, Indiana 46285 United States. Pustilnik A; Eli Lilly Biotechnology Center , 10300 Campus Point Drive, Suite 200, San Diego, California 92121 United States. Kohlman DT; Lilly Research Laboratories, A Division of Eli Lilly & Co. , Lilly Corporate Center, Indianapolis, Indiana 46285 United States. Barr RJ; Lilly Research Laboratories, A Division of Eli Lilly & Co. , Lilly Corporate Center, Indianapolis, Indiana 46285 United States. Bean JS; Lilly Research Laboratories, A Division of Eli Lilly & Co. , Lilly Corporate Center, Indianapolis, Indiana 46285 United States. Dill MJ; Lilly Research Laboratories, A Division of Eli Lilly & Co. , Lilly Corporate Center, Indianapolis, Indiana 46285 United States. SindelarDK; Lilly Research Laboratories, A Division of Eli Lilly & Co. , Lilly Corporate Center, Indianapolis, Indiana 46285 United States. Maletic M; Eli Lilly Biotechnology Center , 10300 Campus Point Drive, Suite 200, San Diego, California 92121 United States. Coghlan MJ; Lilly Research Laboratories, A Division of Eli Lilly & Co. , Lilly Corporate Center, Indianapolis, Indiana 46285 United States.
Pokaż więcej
Źródło:
Journal of medicinal chemistry [J Med Chem] 2015 Aug 27; Vol. 58 (16), pp. 6607-18. Date of Electronic Publication: 2015 Aug 07.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
5-HT1A receptor antagonists reduce food intake and body weight by reducing total meals with no conditioned taste aversion.
Autorzy:
Dill MJ; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, United States. Electronic address: dill_. Shaw J Cramer J SindelarDK
Portal adrenergic blockade does not inhibit the gluconeogenic effects of circulating catecholamines on the liver.
Autorzy:
Chu CA; Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232-0615, USA. SindelarDK Neal DW Cherrington AD
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies